Urine marker beats triple serum test for Down's detection
This article was originally published in Clinica
Executive Summary
A urine marker used for ovarian cancer detection is a more powerful predictor of Down's syndrome than the combined triple serum test and could also be cheaper. The discovery that urinary gonadotropin fragment (UGP) can detect 80% of Down's syndrome pregnancies was first made by Professor Howard Cuckle, at Leeds General Infirmary (UK) in 1994 and has now been confirmed in a US study.